Wearable tech could stop Post-Pregnancy diabetes in its tracks

NCT ID NCT05081037

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether giving women who had gestational diabetes a continuous glucose monitor and a FitBit can help them adopt healthier habits and prevent type 2 diabetes. Participants will wear the sensor for up to 14 days and use the tracker to monitor their activity. The study follows them for up to 4 years to see if these tools reduce diabetes risk and improve overall health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A wearable continuous glucose monitor and a FitBit exercise tracker
What this could lead to
If this works, it could point to a simple, wearable-based lifestyle program that helps women at high risk avoid developing type 2 diabetes after pregnancy.
What could go wrong
This is a relatively small trial, and the devices only help with awareness—they don't directly change behavior. Success depends on whether the women stay motivated to alter their diet and activity long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • KK Women's and Children's Hospital

    Singapore, Singapore, 229899, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.